Article Text

Download PDFPDF

Correction: Phase 2 study of pembrolizumab in patients with advanced rare cancers

Statistics from Altmetric.com

Naing A, Meric-Bernstam F, Stephen B, et al. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J ImmunoTher Cancer 2020;8:e000347. doi: 10.1136/jitc-2019-000347

In the article titled 'Phase 2 study of pembrolizumab in patients with advanced rare cancers', the author name Abulrahman Abonofal is spelt incorrectly. The correct spelling is Abdulrahman Abonofal.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.